Trials for Tirzepatide, a dual GLP-1/GIP (glucagon-like peptide-1 / glucose-dependent insulinotropic polypeptide) agonist, show up to 22.5% body weight reduction
Patients experiencing side effects should consult their prescriber rather than self-adjusting their regimen
Wegovy (Semaglutide Injection) Wegovy is one of the most established GLP-1 weight loss medications available today
As peptide-based medications break down, they may form aggregates or fragments that could theoretically trigger immune responses or allergic reactions
Dr Stephen Lawrence, associate clinical professor at the University of Warwick, warned the medication is not a quick fix or a replacement for following a healthy lifestyle, which includes regular physical activity and healthy eating
Yes as with all GLP-1 medications, side effects are possible